$YARW 8-K SEC Filings

Filed On	Filing
14 Sep 2026	8-K: Entry into a Material Definitive Agreement Introductory. Yarrow Bioscience, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 5,769,231 shares of its common stock, par valu...
10 Sep 2026	8-K: Other Events 1 Bringing life into balance Yarrow Bioscience Overview September 2026
30 Jul 2026	8-K: Other Events
28 Jul 2026	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +8 more
21 Jul 2026	8-K: Regulation FD Disclosure; Other Events
20 Jul 2026	8-K: Submission of Matters to a Vote of Security Holders
14 Jul 2026	8-K: Regulation FD Disclosure
10 Jul 2026	8-K: Regulation FD Disclosure; Other Events
21 May 2026	8-K: Regulation FD Disclosure
11 Mar 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
30 Jan 2026	8-K: Entry into a Material Definitive Agreement
17 Dec 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +3 more
12 Dec 2025	8-K: Submission of Matters to a Vote of Security Holders
06 Nov 2025	8-K: Results of Operations and Financial Condition
12 Sep 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
14 Aug 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
30 Jul 2025	8-K: Results of Operations and Financial Condition; Other Events
08 May 2025	8-K: Results of Operations and Financial Condition
06 Mar 2025	8-K: Results of Operations and Financial Condition
13 Jan 2025	8-K: Other Events

Comments